Evidence map›Paper›PMID 29581529›Full record

ArticleScientific reports2018

Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse.

Sofia Nordling, Johan Brännström, Fredrik Carlsson, Bo Lu, Evelyn Salvaris, Alkwin Wanders, Jos Buijs, Sergio Estrada, Vladimir Tolmachev, Peter J Cowan and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Glycocalyx in Endotoxemia and Sepsis.The American journal of pathology · 2020
    Review
  14. Review
  15. Circulating mitochondria in organ donors promote allograft rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Sofia NordlingDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-9084-3455
Johan BrännströmDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Fredrik CarlssonDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Bo LuImmunology Research Centre, St Vincent's Hospital Melbourne, Victoria, Australia.
Evelyn SalvarisImmunology Research Centre, St Vincent's Hospital Melbourne, Victoria, Australia.
Alkwin WandersDepartment of Medical Biosciences, Umeå University, Umeå, Sweden.ORCID 0000-0002-1690-6363
Jos BuijsDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-3955-1320
Sergio EstradaDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Vladimir TolmachevDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-6122-1734
Peter J CowanImmunology Research Centre, St Vincent's Hospital Melbourne, and Department of Medicine, University of Melbourne, Victoria, Australia.ORCID 0000-0001-9016-4954
Tomas LorantDepartment of Surgical Sciences, Section of Transplantation Surgery, Uppsala University, Uppsala, Sweden.
Peetra U MagnussonDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. peetra.magnusson@igp.uu.se.ORCID 0000-0003-1142-854X
Uppsala University · SESt Vincent's Hospital Melbourne · AUThe University of Melbourne · AUUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia reperfusion injury is one of the major complications responsible for delayed graft function in kidney transplantation. Applications to reduce reperfusion injury are essential due to the widespread use of kidneys from deceased organ donors where the risk for delayed graft function is especially prominent. We have recently shown that coating of inflamed or damaged endothelial cells with a unique heparin conjugate reduces thrombosis and leukocyte recruitment. In this study we evaluated the binding capacity of the heparin conjugate to cultured human endothelial cells, to kidneys from brain-dead porcine donors, and to murine kidneys during static cold storage. The heparin conjugate was able to stably bind cultured endothelial cells with high avidity, and to the renal vasculature of explanted kidneys from pigs and mice. Treatment of murine kidneys prior to transplantation reduced platelet deposition and leukocyte infiltration 24 hours post-transplantation, and significantly improved graft function. The present study thus shows the benefits of enhanced protection of the renal vasculature during cold storage, whereby increasing the antithrombotic and anti-adhesive properties of the vascular endothelium yields improved renal function early after transplantation.

Indexed as

Kidney TransplantationAnimalsBrain DeathCryopreservationDelayed Graft FunctionEndothelium, VascularGraft SurvivalHeparinHumansKidneyMiceRenal VeinsReperfusion InjurySwineTissue DonorsHeparin

Identifiers

PMID29581529
PMCPMC5979943
OpenAlexW2803417908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.